Quantitative mapping of proteasome interactomes and substrates using ProteasomeID.
Aleksandar BartolomeJulia C HeibyDomenico Di FraiaIvonne HeinzeHannah KnaudtEllen SpäthOmid OmraniAlberto MinettiMaleen HofmannJoanna M KirkpatrickTherese DauAlessandro OriPublished in: eLife (2024)
Proteasomes are essential molecular machines responsible for the degradation of proteins in eukaryotic cells. Altered proteasome activity has been linked to neurodegeneration, auto-immune disorders and cancer. Despite the relevance for human disease and drug development, no method currently exists to monitor proteasome composition and interactions in vivo in animal models. To fill this gap, we developed a strategy based on tagging of proteasomes with promiscuous biotin ligases and generated a new mouse model enabling the quantification of proteasome interactions by mass spectrometry. We show that biotin ligases can be incorporated in fully assembled proteasomes without negative impact on their activity. We demonstrate the utility of our method by identifying novel proteasome-interacting proteins, charting interactomes across mouse organs, and showing that proximity-labeling enables the identification of both endogenous and small-molecule-induced proteasome substrates.
Keyphrases
- small molecule
- mass spectrometry
- mouse model
- high resolution
- endothelial cells
- squamous cell carcinoma
- papillary thyroid
- liquid chromatography
- oxidative stress
- cell proliferation
- diabetic rats
- high performance liquid chromatography
- endoplasmic reticulum stress
- lymph node metastasis
- young adults
- induced pluripotent stem cells
- childhood cancer